Login
Join
FOLLOW:
Subscribe Free
Magazine
eNewsletter
Checkout
Menu
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
More
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
Current / Back Issue
Features
Editorial
Columns
Digital Edition
eNewsletter Archive
Our Team
Editorial Guidelines
Subscribe Now
Advertise Now
Top Features
Working in Tandem: Effective Security for Weight-loss Drug Packaging
Navigating Global CDMO Trends
Anti-Counterfeiting Technology
Making the Most of Real-World Data in Clinical Trials
Inflation Reduction Act and the Impact on Biosimilars
Breaking News
Online Exclusives
Industry News
Collaborations & Alliances
Promotions & Moves
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
CRO News
Live From Shows
Top News
Lilly Acquires Manufacturing Facility from Nexus Pharmaceuticals
Kühne Holding AG Agrees to Acquire Aenova Group
BigHat Biosciences Partners with Janssen Biotech to Guide Antibody Discovery & Design
Moderna and OpenAI Join Forces to Transform Healthcare with AI
CureVac Names New Chief Business Officer
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
Lilly Acquires Manufacturing Facility from Nexus Pharmaceuticals
Hanmi, Merck Enter Clinical Collaboration & Supply Agreement
Particle Dynamics Names New Chief Financial Officer
Vertex Obtains Exclusive License to TreeFrog’s C-Stem Technology
BMS & Cellares Announce Worldwide Capacity Reservation & Supply Agreement
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Tower Cold Chain Introduces KTEvolution 12 Containers
Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model
[WEBINAR] Headspace Gas Ingress Methods - The Golden Tool for Container Closure Integrity Testing
[WEBINAR] Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model
Headspace Gas Ingress Methods - The Golden Tool for Container Closure Integrity Testing
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Kühne Holding AG Agrees to Acquire Aenova Group
BigHat Biosciences Partners with Janssen Biotech to Guide Antibody Discovery & Design
Tetra Pharm Technologies & Glysious Partner to Develop Transdermal Combination Drugs
Sanofi’s Rilzabrutinib Meets Primary Endpoint in ITP
Tharimmune Announces Option for Novel HER2/HER3 Cancer Therapies
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Cellares Launches Cell Q Automated cGMP QC Workcell for Cell Therapies
TATAA Biocenter Awarded GLP Accreditation
Anti-Counterfeiting Technology
Do You Know Your Product's Impurity Profile?
Inflation Reduction Act and the Impact on Biosimilars
Companies
Categories
Corporate Capabilities
Add New Company
Contract Service Directory Companies
Abzena
Vetter Pharma International
INCOG BioPharma Services
Solvias USA, LLC
LOTTE BIOLOGICS
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Jobs
Contract Service Directory Companies
Abzena
Vetter Pharma International
INCOG BioPharma Services
Solvias USA, LLC
LOTTE BIOLOGICS
Webinars
Live From Shows
Magazine
Current / Back Issue
Features
Editorial
Columns
Editorial Guidelines
Subscribe Now
Advertise Now
Enewsletter Archive
Digital Edition
Directory
Companies
Categories
Corporate Capabilities
Add Your Company
Manufacturing
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
cGMP Manufacture
Packaging
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Development
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Compliance
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Top 20 Pharma & BioPharma
Contract Pharma Direct
Breaking News
Online Exclusives
Slideshows
Experts Opinions
Surveys
Outsourcing Survey
Salary Survey
Glossary
Videos
White Papers
Podcasts
Infographics
Microsites
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Contract Pharma Conference
Contract Pharma Conference
Speakers
Exhibitors
Conference Sessions
eBook
Webinars
Events
Industry Events
Live from Show Events
Webinars
Classifieds / Job Bank
Classifieds
Job Bank
About Us
About Us
Contact Us
Advertise With Us
Privacy Policy
Terms of Use
Collaborations & Alliances
All News
Bio News
Breaking News
Collaborations & Alliances
CRO News
Custom Sourcing News
Financial Reports
Industry News
Packaging & Tracking
Pharma Matters Q&A
Promotions & Moves
Reader Showcase
Trials & Filings
VideoBites
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
cGMP Manufacture
|
Collaborations & Alliances
|
Facilities
|
Industry News
SK pharmteco Doubles Viral Vector Production Capacity in Europe
Operation of the second facility to kick start in 2024.
06.23.23
Breaking News
|
Collaborations & Alliances
|
Drug Development
SCYNEXIS Achieves $25M GSK Development Milestone
Payment follows a development goal for the Phase 3 MARIO study for ibrexafungerp in invasive candidiasis.
06.21.23
Collaborations & Alliances
|
Drug Development
Abu Dhabi DoH, AbbVie, M42 Partner on Personalized Medicine
Aims to advance precision medicine in the diagnosis and treatment of multiple myeloma and non-small cell lung cancer in UAE.
06.20.23
Breaking News
|
Collaborations & Alliances
|
Drug Development
|
Drug Discovery
MIMETAS, Astellas Expand Strategic Immuno-Oncology Alliance
To include automation and application support leveraging MIMETAS' disease modeling platform.
06.20.23
Breaking News
|
Clinical Trials
|
Collaborations & Alliances
|
CRO News
|
Drug Development
MRCT Center, Medable Launch Review Toolkit for Decentralized Trials
Aims to standardize guidelines for streamlined IRB/Ethics review of DCT applications.
06.20.23
Biologics, Proteins, Vaccines
|
Breaking News
|
cGMP Manufacture
|
Collaborations & Alliances
Be The Match BioTherapies to Support Garuda Therapeutics’ Cell Therapies
Partnership aims to provide broad access to consistent, durable, HLA-compatible and transgene-free blood stem cell therapies.
06.19.23
Breaking News
|
Collaborations & Alliances
|
Drug Development
|
Drug Discovery
|
R&D
Cholesgen, AstraZeneca Enter R&D Alliance in Hypercholesterolemia
Aims to validate genetic drug targets and progress therapeutic molecules into clinical development.
06.16.23
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
SCTbio, Cyto-care Partner to Improve Cell Therapy Capabilities
Aims to address need for efficient collection, cryopreservation, quality control and logistics capabilities of leukapheresis materials.
06.16.23
APIs
|
Breaking News
|
Collaborations & Alliances
|
Drug Delivery
Nanoform, Celanese Demonstrate Enhanced Drug Delivery Technology
Alliance aims to enable enhanced sustained release properties by reducing the initial burst release of a drug.
06.15.23
Aseptic Processing
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
Culture Biosciences, Cytiva Partner to Innovate Upstream Bioprocessing
Aims to provide greater access to predictive and robust scale-up capabilities.
06.15.23
Breaking News
|
Collaborations & Alliances
|
Drug Development
|
Drug Discovery
Astellas, Cullgen Partner to Advance Targeted Protein Degraders
To combine Cullgen's uSMITE targeted protein degradation platform featuring novel E3 ligands with Astellas' drug discovery capabilities.
06.15.23
Breaking News
|
Collaborations & Alliances
|
Drug Delivery
|
Drug Development
Thaerapy, Resyca Ink License Agreement for Soft Mist Inhaler Technology
Resyca will receive a signing milestone as well as other milestones for the supply of soft-mist inhalers for Thaerapy’s clinical trials.
06.15.23
Biologics, Proteins, Vaccines
|
Breaking News
|
cGMP Manufacture
|
Collaborations & Alliances
Orgenesis, U of California, Davis Partner for CGT Mobile Processing Units and Labs
Orgenesis will install and operate OMPULs, enabling their POCare service platform to manufacture therapeutics at hospitals.
06.14.23
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
Applied StemCell, CIRM Partner on Resources for Regenerative Therapies
To provide access to clinical-grade iPSCs and gene editing technologies to accelerate development.
06.13.23
Breaking News
|
Collaborations & Alliances
|
Drug Development
HanAll Biopharma, Daewoong Pharma Invest in Vincere Biosciences
Fosters collaborative opportunities in Parkinson's Disease therapeutics as well as Vincere's artificial intelligence platform.
06.12.23
Bioanalytical Services
|
Breaking News
|
cGMP Manufacture
|
Collaborations & Alliances
|
Drug Development
Mendus, NorthX Biologics Enter Strategic Cell Therapy Manufacturing Alliance
To establish cell therapy manufacturing capabilities in Sweden for the large-scale manufacturing of Mendus’ lead program vididencel.
06.12.23
Breaking News
|
Collaborations & Alliances
|
Drug Development
Quell Therapeutics, AstraZeneca Partner on Engineered Treg Cell Therapies
Collaboration focused on two autoimmune disease areas: Type 1 diabetes and inflammatory bowel disease.
06.09.23
Breaking News
|
Collaborations & Alliances
|
Drug Development
Astellas, KateTx Enter Exclusive License Agreement to Develop KT430
Next-gen investigational gene therapy to treat X-linked myotubular myopathy (XLMTM), a life-threatening, rare neuromuscular disease.
06.08.23
Bio News
|
Breaking News
|
Collaborations & Alliances
Pharma D&S Group merges with ProductLife Group
ProductLife Group plans to merge with Italy’s Pharma D&S Group.
06.08.23
Breaking News
|
cGMP Manufacture
|
Collaborations & Alliances
|
Drug Development
|
Fill/Finish
|
Process Development
|
Scale-up/Technology Transfer
GenScript ProBio, Comprehensive Cell Solutions Partner to Expedite CGTs
Aims to help drug developers navigate the challenges of regulatory compliance, quality assurance, and production scalability.
06.08.23
Breaking News
Lilly Acquires Manufacturing Facility from Nexus Pharmaceuticals
Kühne Holding AG Agrees to Acquire Aenova Group
BigHat Biosciences Partners with Janssen Biotech to Guide Antibody Discovery & Design
Moderna and OpenAI Join Forces to Transform Healthcare with AI
CureVac Names New Chief Business Officer
View Breaking News >
CURRENT ISSUE
April 2024
Anti-Counterfeiting Technology
Navigating Global CDMO Trends
Weight-loss Drug Packaging
Clinical Supply CDMOs
Industry Experts Weigh in on Oral Solid Dosage
Newsmakers Q&A: Almac Group
Economical Mobile Workstations for Lower-Grade Cleanrooms
Pharmaceutical Manufacturing Equipment & Trends
Insight Into Obesity-Related Clinical Research
Inflation Reduction Act and the Impact on Biosimilars
View More >